JP2008535855A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535855A5
JP2008535855A5 JP2008505605A JP2008505605A JP2008535855A5 JP 2008535855 A5 JP2008535855 A5 JP 2008535855A5 JP 2008505605 A JP2008505605 A JP 2008505605A JP 2008505605 A JP2008505605 A JP 2008505605A JP 2008535855 A5 JP2008535855 A5 JP 2008535855A5
Authority
JP
Japan
Prior art keywords
cancer
ddr2
antibody
level
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008505605A
Other languages
English (en)
Japanese (ja)
Other versions
JP4942219B2 (ja
JP2008535855A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/013162 external-priority patent/WO2006110587A2/en
Publication of JP2008535855A publication Critical patent/JP2008535855A/ja
Publication of JP2008535855A5 publication Critical patent/JP2008535855A5/ja
Application granted granted Critical
Publication of JP4942219B2 publication Critical patent/JP4942219B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008505605A 2005-04-07 2006-04-07 癌の診断、検出および処置におけるｄｄｒ２ Expired - Fee Related JP4942219B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66986005P 2005-04-07 2005-04-07
US60/669,860 2005-04-07
PCT/US2006/013162 WO2006110587A2 (en) 2005-04-07 2006-04-07 Ddr2 in cancer diagnosis, detection and treatment

Publications (3)

Publication Number Publication Date
JP2008535855A JP2008535855A (ja) 2008-09-04
JP2008535855A5 true JP2008535855A5 (enExample) 2009-03-26
JP4942219B2 JP4942219B2 (ja) 2012-05-30

Family

ID=37023020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008505605A Expired - Fee Related JP4942219B2 (ja) 2005-04-07 2006-04-07 癌の診断、検出および処置におけるｄｄｒ２

Country Status (6)

Country Link
US (1) US20100068207A1 (enExample)
EP (1) EP1899482A2 (enExample)
JP (1) JP4942219B2 (enExample)
AU (1) AU2006235264A1 (enExample)
CA (1) CA2604884A1 (enExample)
WO (1) WO2006110587A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652472B2 (en) 2006-12-05 2014-02-18 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
WO2013151677A1 (en) * 2012-04-02 2013-10-10 Broad Institute, Inc. Ddr2 mutations in cancer
US9499856B2 (en) 2012-04-02 2016-11-22 The Board Institute, Inc. DDR2 mutations in squamous cell lung cancer
WO2014105966A2 (en) 2012-12-27 2014-07-03 Quest Diagnostics Investments Incorporated Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
KR101462329B1 (ko) 2013-01-30 2014-11-21 중앙대학교 산학협력단 디스코이딘 도메인 리셉터 2의 ｊｍ2 도메인의 발현 촉진제를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
EP3088521A4 (en) * 2013-12-25 2017-08-02 Saga University Method for detecting lung cancer
JP2025528772A (ja) * 2022-08-03 2025-09-02 菲柏生物医学技術（広州）有限公司 抗ｄｄｒ２ナノボディ及びその使用
CN116027038A (zh) * 2022-09-16 2023-04-28 菲创生物医学技术(广州)有限公司 盘状结构域受体2在诊断胶质瘤中的应用及相关的计算机可读介质
CN116626294B (zh) * 2022-09-20 2024-07-09 菲创生物医学技术(广州)有限公司 盘状结构域受体2在诊断神经退行性疾病中的应用及相关的计算机可读介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116330A1 (en) * 2001-04-27 2004-06-17 Kenichiro Naito Preventive/therapeutic method for cancer
JP2004002210A (ja) * 2001-04-27 2004-01-08 Takeda Chem Ind Ltd 癌の予防・治療方法
US20040166490A1 (en) * 2002-12-17 2004-08-26 Morris David W. Novel therapeutic targets in cancer
EP1382969A1 (en) * 2002-07-17 2004-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diagnosis and prevention of cancer cell invasion
WO2004048938A2 (en) * 2002-11-26 2004-06-10 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
WO2004074506A2 (en) * 2003-02-13 2004-09-02 Mergen Ltd Polynucleotide sequences and corresponding encoded polypeptides of particular secreted and membrane-bound proteins overexpressed in certain cancers
WO2004108896A2 (en) * 2003-06-03 2004-12-16 The Board Of Trustees Of The University Of Arkansas Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
MXPA05014220A (es) * 2003-07-02 2006-03-09 Novartis Ag Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos.
ATE459886T1 (de) * 2003-07-11 2010-03-15 Robert Zeillinger Verfahren zur vorhersage der metastasefähigkeit von mammakarzinom
WO2005007830A2 (en) * 2003-07-14 2005-01-27 Mayo Foundation For Medical Education And Research Methods and compositions for diagnosis, staging and prognosis of prostate cancer
WO2005015236A2 (en) * 2003-07-18 2005-02-17 Roche Diagnostics Gmbh A method for predicting the progression of adenocarcinoma

Similar Documents

Publication Publication Date Title
US9671405B2 (en) Identifying taxane sensitivity in prostate cancer patients
KR102571924B1 (ko) c-MAF 상태에 기초한 유방암의 치료
US9435812B2 (en) Expression of ETS related gene (ERG) and phosphatase and tensin homolog (PTEN) correlates with prostate cancer capsular penetration
JP2008535494A5 (enExample)
WO2010017515A2 (en) Breast cancer specific markers and methods of use
JP2006520781A5 (enExample)
CN103328500B (zh) 用于癌症的诊断和治疗的方法和化合物
JP2008535856A5 (enExample)
CN112626207B (zh) 一种用于区分非侵袭性和侵袭性无功能垂体腺瘤的基因组合
CA2807104C (en) Bard1 isoforms in lung and colorectal cancer and use thereof
JP2008535855A5 (enExample)
Rudzińska et al. The role of podoplanin in the biology of differentiated thyroid cancers
JP2005520543A5 (enExample)
WO2013001369A4 (en) Therapeutic and diagnostic target
CN102471801B (zh) 用Δ133p53β检验被认为倾向于具有转移性癌症的受试者的方法
WO2009141440A1 (en) Netrin-1 overexpression as a biological marker and a survival factor for aggressive neuroblastoma
US20150168410A1 (en) Biomarkers for colorectal cancer diagnosis and prediction
JP2014517282A (ja) 膀胱癌におけるｒｂｍ３
JP2008535854A5 (enExample)
US20220381787A1 (en) Novel lox-1 antibody compositions, lox1 neutralization assay and methods of treatment using same
KR102897399B1 (ko) 유방암 진단을 위한 신규 바이오마커
JP2009523004A5 (enExample)
WO2008031165A1 (en) Methods and compositions for the diagnosis and treatment of tumours
JP2008535491A5 (enExample)
US20230133776A1 (en) Methods for diagnosing cancer